A woman in her fifties with left bundle branch block and recurrent arrhythmias

Insights

Cardiac sarcoidosis, an inflammatory condition affecting the heart, can be difficult to diagnose. Early recognition of arrhythmias and cardiac dysfunction is crucial for timely intervention and improved patient outcomes.

Area of Science:

  • Cardiology
  • Immunology
  • Pulmonology

Background:

  • Sarcoidosis is a systemic inflammatory disease characterized by non-caseating granulomas.
  • Cardiac involvement in sarcoidosis significantly worsens prognosis due to potential damage to the heart's electrical system.
  • Diagnosing cardiac sarcoidosis presents challenges due to the limitations of current clinical criteria.

Observation:

  • A middle-aged woman presented with chronic dry cough and atypical chest pain, initially undiagnosed for years.
  • The patient experienced recurrent arrhythmias, progressive ventricular dysfunction, and eventual heart failure.
  • A comprehensive, multidisciplinary evaluation ultimately identified cardiac sarcoidosis as the underlying cause.

Findings:

  • Cardiac sarcoidosis can manifest subtly but should be suspected with left bundle branch block, AV-block, or supraventricular tachycardias.
  • Weakened ventricular function is a critical sign warranting further investigation for cardiac sarcoidosis.
  • Diagnostic tools include MRI, echocardiography, PET/CT scans, and endomyocardial biopsy for definitive confirmation.

Implications:

  • Timely diagnosis and management of cardiac sarcoidosis are crucial for preventing severe cardiac complications.
  • Multidisciplinary collaboration and advanced imaging techniques improve diagnostic accuracy.
  • Understanding sarcoidosis's cardiac manifestations is vital for patient prognosis and treatment strategies.
Abstract

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
204
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
286
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
76
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
126
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
142
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
131